SEC Tracker
Get the app

Intuitive Surgical ISRG

Intuitive Surgical Q3 FY24: revenue $2.0B; diluted EPS $1.56

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Intuitive Surgical reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Revenue$2.0BNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Net income$565.1MNo year-earlier figure tagged10-Q income statement, on EDGAR
  3. Diluted EPS$1.56No year-earlier figure tagged10-Q income statement, on EDGAR
  4. Cash and cash equivalents$2.4BNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  5. Cash from operations$706.5MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Intuitive Surgical files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (3842) and public float over $2B, nearest public float first, as each company reports it on its annual report cover.

  1. Edwards Lifesciences EW public float $45.9B, Jun 30, 2025
  2. STERIS STE public float $24.2B, Sep 30, 2025
  3. Zimmer Biomet Holdings ZBH public float $18.0B, Jun 30, 2025
  4. Align Technology ALGN public float $11.1B, Jun 30, 2025
  5. MSA Safety MSA public float $6.5B, Jun 30, 2025